IT201900022203A1 - Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne - Google Patents

Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Info

Publication number
IT201900022203A1
IT201900022203A1 IT102019000022203A IT201900022203A IT201900022203A1 IT 201900022203 A1 IT201900022203 A1 IT 201900022203A1 IT 102019000022203 A IT102019000022203 A IT 102019000022203A IT 201900022203 A IT201900022203 A IT 201900022203A IT 201900022203 A1 IT201900022203 A1 IT 201900022203A1
Authority
IT
Italy
Prior art keywords
neoplasies
salmon
diagnostics
malignant
therapy
Prior art date
Application number
IT102019000022203A
Other languages
English (en)
Inventor
Cusani Alberto Bartorelli
Original Assignee
Cusani Alberto Bartorelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cusani Alberto Bartorelli filed Critical Cusani Alberto Bartorelli
Priority to IT102019000022203A priority Critical patent/IT201900022203A1/it
Priority to MX2022006278A priority patent/MX2022006278A/es
Priority to JP2022530848A priority patent/JP2023504241A/ja
Priority to US17/756,262 priority patent/US20230000946A1/en
Priority to CA3159292A priority patent/CA3159292A1/en
Priority to PCT/EP2020/083069 priority patent/WO2021105059A1/en
Priority to CN202080081596.6A priority patent/CN114761034A/zh
Priority to EP20820795.1A priority patent/EP4065154A1/en
Publication of IT201900022203A1 publication Critical patent/IT201900022203A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
IT102019000022203A 2019-11-26 2019-11-26 Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne IT201900022203A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT102019000022203A IT201900022203A1 (it) 2019-11-26 2019-11-26 Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
MX2022006278A MX2022006278A (es) 2019-11-26 2020-11-23 Proteinas de salmon uk 114 para uso en el tratamiento, diagnostico y prevencion de tumores malignos.
JP2022530848A JP2023504241A (ja) 2019-11-26 2020-11-23 悪性腫瘍の治療、診断および予防に使用するためのｕｋ１１４サケタンパク質
US17/756,262 US20230000946A1 (en) 2019-11-26 2020-11-23 Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours
CA3159292A CA3159292A1 (en) 2019-11-26 2020-11-23 Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours
PCT/EP2020/083069 WO2021105059A1 (en) 2019-11-26 2020-11-23 Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours
CN202080081596.6A CN114761034A (zh) 2019-11-26 2020-11-23 Uk 114鲑鱼蛋白用于治疗、诊断和预防恶性肿瘤
EP20820795.1A EP4065154A1 (en) 2019-11-26 2020-11-23 Uk 114 salmon proteins for use in the treatment, diagnosis and prevention of malignant tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000022203A IT201900022203A1 (it) 2019-11-26 2019-11-26 Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Publications (1)

Publication Number Publication Date
IT201900022203A1 true IT201900022203A1 (it) 2021-05-26

Family

ID=70009105

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000022203A IT201900022203A1 (it) 2019-11-26 2019-11-26 Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Country Status (8)

Country Link
US (1) US20230000946A1 (it)
EP (1) EP4065154A1 (it)
JP (1) JP2023504241A (it)
CN (1) CN114761034A (it)
CA (1) CA3159292A1 (it)
IT (1) IT201900022203A1 (it)
MX (1) MX2022006278A (it)
WO (1) WO2021105059A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002567A1 (en) 1994-07-14 1996-02-01 Zetesis S.P.A. Proteins from mammalian liver and their use in oncology
WO1996014340A1 (en) * 1994-11-04 1996-05-17 Zetesis S.P.A. Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
WO2000063368A1 (en) 1999-04-15 2000-10-26 Zetesis S.P.A. Recombinant protein uk114 and its use in therapy and diagnostics
WO2018109096A1 (en) * 2016-12-16 2018-06-21 Alberto Bartorelli Cusani Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002567A1 (en) 1994-07-14 1996-02-01 Zetesis S.P.A. Proteins from mammalian liver and their use in oncology
WO1996014340A1 (en) * 1994-11-04 1996-05-17 Zetesis S.P.A. Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
WO2000063368A1 (en) 1999-04-15 2000-10-26 Zetesis S.P.A. Recombinant protein uk114 and its use in therapy and diagnostics
WO2018109096A1 (en) * 2016-12-16 2018-06-21 Alberto Bartorelli Cusani Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours
EP3554639A1 (en) 2016-12-16 2019-10-23 Alberto Bartorelli Cusani Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BARTORELLI A ET AL., INT J ONCOL., vol. 8, no. 3, March 1996 (1996-03-01), pages 543 - 8
BARTORELLI ET AL., J. TUMOR AND MARKER ONCOLOGY, vol. 9, 1994, pages 37
BUSSOLATI G ET AL., INT J ONCOL., vol. 10, no. 4, April 1997 (1997-04-01), pages 779 - 85
CECILIANI F. ET AL., FEBS LETTERS, vol. 393, 1996, pages 147 - 150
COLOMBO I ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1442, 1998, pages 49 - 59
DHAWAN L ET AL., MOL. CELL. BIOL., vol. 32, 2012, pages 3768 - 3775
ERNST DC ET AL., J. BACTERIOLOGY, vol. 196, no. 18, 2014, pages 3335 - 3342
FLYNN JM ET AL., MOL. MICROBIOL., vol. 89, no. 4, 2013, pages 751 - 759
LAMBRECHT JA ET AL., J.BIOL. CHEM., vol. 287, 2012, pages 34401 - 34407
MYSTINIENE ET AL., BIOCONJUGATE CHEM., vol. 14, 2003, pages 1243 - 1252
NIEHAUS TD ET AL., BMC GENOMICS, vol. 16, 2015, pages 382
RACCA S ET AL: "Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114", VIRCHOWS ARCHIV, SPRINGER INTERNATIONAL, BERLIN, DE, vol. 431, no. 5, 1 November 1997 (1997-11-01), pages 323 - 328, XP002267961, ISSN: 0945-6317, DOI: 10.1007/S004280050106 *

Also Published As

Publication number Publication date
CN114761034A (zh) 2022-07-15
EP4065154A1 (en) 2022-10-05
US20230000946A1 (en) 2023-01-05
MX2022006278A (es) 2022-08-15
JP2023504241A (ja) 2023-02-02
WO2021105059A1 (en) 2021-06-03
CA3159292A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
EP4295846A3 (en) Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
CR20220240A (es) Inhibidores de ras
MX2021013661A (es) Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos.
WO2019083990A3 (en) IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-α (FAP-α)
BR112018008326A2 (pt) composições e métodos para o tratamento de câncer
EP3636752A4 (en) NEW HYALURONIC ACID HYDROLYZING ENZYMUTANTS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THIS
MX2023013435A (es) Composiciones y metodos para expresar otoferlina.
BR112019017403A2 (pt) composições e métodos para o tratamento de câncer
MX2022007994A (es) Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos.
AU2016304856A8 (en) Mechanism of resistance to BET bromodomain inhibitors
PH12020551716A1 (en) Anti-ror antibody constructs
EP3768698A4 (en) METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSIVE GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
MX2021015628A (es) Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso.
HUE059149T2 (hu) 2,4-Diaminokinazolin származékok és azok alkalmazása vírusfertõzések, rák vagy allergiák kezelésében
BR112021016056A2 (pt) Anticorpos de claudina 6 e usos dos mesmos
EP3749315A4 (en) ALPHA-POLYGLUTAMATED RALTITREXED AND USES THEREOF
EP3915985A4 (en) PYRROLOPYRIDINE DERIVATIVE AND ITS USE IN THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASE
WO2017143115A3 (en) Enhancing the therapeutic activity of an immune checkpoint inhibitor
EP4013445A4 (en) THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS
MX2020010932A (es) Enzimas quinureninasa humanas y sus usos.
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
IL280218A (en) Methods for the treatment of HFPEF using dapagliflozin and compounds containing it
IT201900022203A1 (it) Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
MX2022000263A (es) Nuevos antigenos y metodos contra el cancer.